LNSR — LENSAR, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1320350 ·
Last close
$4.91
Market Cap
$60.36M
52W High
$12.94
52W Low
$4.30
ADV30
63,485
Next earnings
2026-11-10
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 — — — — — — —
Jun 2026 16,495,000 9,776,000 2,134,000 3,535,000 69,558,000 13,565,000 54,653,000
Mar 2026 13,428,000 6,382,000 2,239,000 36,332,000 66,223,000 12,494,000 55,433,000
Dec 2025 16,025,000 6,937,000 -4,919,000 -1,458,000 71,430,000 12,974,000 97,449,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-4,646,000
Investing CF
$9,098,000
Financing CF
$533,000
CapEx
$-195,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.40
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-142,431,000
Inventory
$25,141,000
Receivables
$5,623,000
ST Investments
$0
EBIT TTM
$-1,979,000
Pretax Income TTM
$33,686,000
Interest Exp TTM
—
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$60,079,000
EBITDA
$2,504,000
Free Cash Flow
$-14,082,875
Enterprise Value
$64,819,204
Total Cash
$12,622,000
Total Debt
$2,186,000
Shares Out
12,294,241
Trailing EPS
$0.44
Book Value
$0.90
ROE
529.3%
ROA
-1.8%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 58,435,000 -24,578,000 -34,280,000 71,430,000 97,449,000 -26,019,000 -14,831,000
Dec 2024 53,494,000 -6,936,000 -31,404,000 66,297,000 61,435,000 4,862,000 -2,275,000
Dec 2023 42,164,000 -12,229,000 -14,383,000 69,585,000 36,156,000 33,429,000 -9,659,000
Dec 2022 35,358,000 -20,177,000 -19,914,000 55,844,000 13,860,000 41,984,000 -14,856,000

TTM Snapshot

Revenues TTM
$60,264,000
NetIncome TTM
$34,696,000
OpCashFlow TTM
—
Assets (Latest)
$69,558,000
Forward EPS
$-0.85

Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)

max pain strike: $5.00 · spot: $4.85 · call volume: 205 · put volume: 5
Expected Move to 2027-01-15: ±$0.95 (19.59%) — implied range $3.90 – $5.80 · ATM straddle on $5.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
QTEX QTREX Quantum Ltd. $60.72M $1.09 —
OM Outset Medical, Inc. $59.64M $3.16 —
MDNC Medinotec Inc. $58.78M $5.00 —
CNXU Conexeu Sciences Inc. $56.41M $2.00 —
POSC POSITRON CORP $55.84M $1.70 —

News headlines (Yahoo Finance, 1h cache)

LENSAR Inc (LNSR) (Q3 2026) Earnings Call Highlights: Recurring Revenue Surges 17% as Margins ...
2026-11-10 21:07 · Yahoo
LENSAR (LNSR) Q3 2026 Earnings Call Transcript
2026-11-10 19:53 · Yahoo
LENSAR, Inc. Q3 2026 Earnings Call Summary
2026-11-10 17:57 · Yahoo
LENSAR® Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-10 12:00 · Yahoo
LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
2026-11-03 13:00 · Yahoo
LENSAR (LNSR) Q2 2026 Earnings Call Transcript
2026-08-20 14:13 · Yahoo
LENSAR Inc (LNSR) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge
2026-08-13 23:07 · Yahoo
LENSAR Q2 Earnings Call Highlights
2026-08-13 17:04 · Yahoo
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
2026-08-13 11:00 · Yahoo
LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026
2026-08-06 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.